Login to Your Account

Euroscience Open Forum 2012

IMI on the Move to Improve Drug Development in Europe

By Nuala Moran
Staff Writer

Wednesday, July 18, 2012
DUBLIN, Ireland – It has not been long since the first research programs got under way, but there is evidence already that projects undertaken by the €2 billion (US$2.4 billion) Innovative Medicines Initiative (IMI) are having an impact on the environment for drug development in Europe.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription